nicotine
NDC 0363-1825, nicotine polacrilex, lozenge, from Walgreen Company.
- Product NDC
- 0363-1825
- Status
- Listed
- Labeler
- Walgreen Company
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA203690
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0363-1825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE2 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0363-1825-07 | 00363182507 | 3 CONTAINER in 1 CARTON (0363-1825-07) / 27 LOZENGE in 1 CONTAINER |
| 0363-1825-09 | 00363182509 | 27 LOZENGE in 1 CONTAINER (0363-1825-09) |
| 0363-1825-60 | 00363182560 | 1 CONTAINER in 1 CARTON (0363-1825-60) / 20 LOZENGE in 1 CONTAINER |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0363-1825 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0363-1825 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0363-1825. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.